You need to be logged in to view this video

Reprogramming the Course of Cancer and Diabetes

Released on Wednesday, June 10, 2020BIOTECH
Genprex is reprogramming the course of cancer and diabetes. Genprex's CEO, Rodney Varner, will provide an investor presentation with an overview of company highlights, recent milestones, and clinical updates for its oncology and auto-immune disease programs.

Rodney Varner
Genprex, Inc., CEO and Chairman of the Board

Trending Now


Filter By Category
Filter By Keywords
Loading...